LATAM Bif Registry: March 2021 Report

Know the new data from The Latin American Registry of Coronary Bifurcation Percutaneous Intervention  from March 2021. The registry is close to 250 patients (25% increase compared to the prior month) and continues to consolidate month after month. 

For those who are still unfamiliar with it, the LATAM Bif Registry is a prospective, multicenter registry aiming at assessing the reality of percutaneous treatment of coronary bifurcations, defining its needs and establishing strategies to further advance the daily clinical practice. 

Know the data

monthly-report-march-2021

How to make part of the LATAM Bif Registry?

Write to latambif@gmail.com. You will receive all the information and documentation required for LATAMBif, coordinated by SOLACI Research.

Why take part in LATAM Bif?

  1. The chance to access your own database dedicated to coronary bifurcations, with unified variables for all centers across Latin America. 
  2. Each center will own their data and will be able to analyze outcomes in real time. 
  3. The chance to interact with centers interested in research and publication throughout the region. 
  4. The chance to present at local and international events the outcomes of LATAM Bif Registry.
  5. In case you might need help to develop research projects and/or carry out statistical analysis, you will have the support of SOLACI Research.
  6. SOLACI Research will provide weekly auditing for all data, initial and annual (mandatory followup), for it to be charged correctly. 

Write now to latambif@gmail.com and start participating of LATAM Bif.


Know more about the LATAM Bif Registry

 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....